These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8924746)

  • 1. Another function of erythrocytes: transport of circulating immune complexes.
    Pascual M; Schifferli JA
    Infusionsther Transfusionsmed; 1995 Oct; 22(5):310-5. PubMed ID: 8924746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of immune complexes by the erythrocyte complement receptor 1 (CR1).
    Pascual M; Schifferli JA
    Immunopharmacology; 1992; 24(2):101-6. PubMed ID: 1473961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological and pathological aspects of circulating immune complexes.
    Schifferli JA; Taylor RP
    Kidney Int; 1989 Apr; 35(4):993-1003. PubMed ID: 2651776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
    Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
    Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
    Craig ML; Waitumbi JN; Taylor RP
    J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
    Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
    Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
    Nardin A; Lindorfer MA; Taylor RP
    Mol Immunol; 1999; 36(13-14):827-35. PubMed ID: 10698336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1).
    Imrie HJ; Jones DR
    Clin Exp Immunol; 1997 Jul; 109(1):217-22. PubMed ID: 9218847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
    Taylor RP; Pocanic F; Reist C; Wright EL
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
    Cosio FG; Shen XP; Hebert LA
    Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
    Madi N; Paccaud JP; Steiger G; Schifferli JA
    Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
    Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
    J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human C3b receptor: function and role in human diseases.
    Tausk F; Gigli I
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):141S-145S. PubMed ID: 2141047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
    Lucisano Valim YM; Lachmann PJ
    Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to complement-bearing immune complexes enhances the in vitro sequestration of erythrocytes from young but not elderly donors.
    Shapiro S; Pilar T; Gershon H
    Clin Exp Immunol; 1993 Feb; 91(2):301-7. PubMed ID: 8428395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.
    Taylor RP; Ferguson PJ; Martin EN; Cooke J; Greene KL; Grinspun K; Guttman M; Kuhn S
    Clin Immunol Immunopathol; 1997 Jan; 82(1):49-59. PubMed ID: 9000042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.